FGFR3 and urinary bladder carcinoma: The combination of the anti-FGFR3 enables the identification of bladder cancer cells while simultaneously inhibiting the proliferation of bladder cancer cell lines, ultimately leading to cellular apoptosis [[66], [67], [68]].